TABLE 4.
Results of treatment within 30 days of embolization in patients using medications associated with increased bleeding or with gastrotoxic effects before the procedure (n=57)
| Patients | n |
|---|---|
| Successful embolization | 41 |
| Previous AC and/or AI | 23 |
| No previous AC and/or AI | 18 |
| Failed embolization | 16 |
| Previous AC and/or AI | 13 |
| No previous AC and/or AI | 3 |
| Previous AC and/or AI | 36 |
| Died | 11 |
| Lived | 25 |
| Without previous AC and/or AI | 21 |
| Died | 5 |
| Lived | 16 |
| Deceased | 16 |
| Previous AC and/or AI | 11 |
| No previous AC and/or AI | 5 |
Anticoagulant medications (AC) include antiplatelets agents, oral vitamin K antagonists, preventive or curative heparin and fibrinolytic agents; Anti-inflammatory drugs (AI) include nonsteroidal anti-inflammatory drugs and corticosteroids